✦ LIBER ✦

484 On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon α-2a (40 kDa) (PEGASYS®)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

491 Sustained HBSAG seroconversion in pa

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

743 The majority of patients with HBeAg-

✍ P. Marcellin; E. Bonino; G.K.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

49 Association between HBeAg seroconvers

✍ T. Piratvisuth; G.K.K. Lau; P. Marcellin; W.C. Chow; G. Cooksley; M.W. Fried; S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P.112 Response is sustained two years po

✍ P. Marcellin; F. Bonino; G.K.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 281 KB

[53] VIROLOGICAL AND BIOCHEMICAL RESPONS

✍ P. Marcellin; F. Bonino; O.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; K. Lu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 264 KB

523 Effect of ALT flares on efficacy and

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 253 KB